AU2006236108A1
|
|
Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
|
AU2005232281A1
|
|
Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
|
AU2002313992B2
|
|
Compositions and Methods for Treatment of Mitochondrial Diseases
|
AU2491301A
|
|
Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
|
NZ504512A
|
|
Peptide from alpha-hemoglobin as a stimulator of stem cell proliferation and used thereof
|
AU5262499A
|
|
Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
|
CN1285751A
|
|
Antimutagenic compositions for treatment and prevention of photodamage to skin
|
US6472378B2
|
|
Compositions and methods for treatment of mitochondrial diseases
|
ZA9802746B
|
|
Inhibitor and stimulator of stem cell proliferation and uses thereof
|
MX9709749A
|
|
Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides.
|
KR20000005428A
|
|
Inhibitor and stimulator of proliferating of liver cell, and their use
|
IL159708D0
|
|
Peptides and their use in manufacturing medicaments and in identifying receptors.
|
US6218519B1
|
|
Compounds and methods for the selective treatment of cancer and bacterial infections
|
US5861483A
|
|
Inhibitor of stem cell proliferation and uses thereof
|
UA54379C2
|
|
Stem cell inhibiting factors, pharmaceutical composition (variants) and methods for their use (variants)
|
US5939391A
|
|
Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
|
WO9604923A1
|
|
Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides
|
CN1156409A
|
|
Pyrimidine nucleotide precursors for treating of systemic inflammation and inflammatory hepatitis
|
AU2915095A
|
|
Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
|
US6348451B1
|
|
Acyl deoxyribonucleoside derivatives and uses thereof
|